 |
|
Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
Taeyun Kim, Yunsuk Choi, Je-Hwan Lee, Silvia Park, Jae-Sook Ahn, Joon-Ho Moon, Ho-Jin Shin, Won Sik Lee, Dajung Kim, Ho Sup Lee
Korean J Intern Med. 2020;35(2):429-437. Published online 2019 Jan 10 DOI: https://doi.org/10.3904/kjim.2018.317
|
|
Citations to this article as recorded by
 The frequencies of lymphocyte subsets on “day 30″ correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation
Yanhua Yao, Bohan Li, Jie Li, Di Yao, Jing Ling, Yixin Hu, Liyan Fan, Lin Wan, Lingjun Kong, Peifang Xiao, Jun Lu, Lijun Meng, Zhiheng Li, Shaoyan Hu, Yuanyuan Tian
Immunology Letters.2023; 254: 21. CrossRef Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis
Joice Zuckermann, Bruno Mateus de Castro, Thiago Almirante Cunha, Alessandra Paz, Leila Beltrami Moreira, Benigno C. Valdez
PLOS ONE.2023; 18(4): e0284476. CrossRef
|